AC
TTOO

Armistice Capital’s T2 Biosystems, Inc TTOO Stock Holding History

Armistice Capital’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,396,000
Closed -$2.75M – 318
2024
Q3 		$2.75M Sell
1,396,000
-262,000
-16% -$994K 0.04% 148
2024
Q2 		$8.85M Buy
+1,658,000
New +$6.92M 0.11% 96

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Armistice Capital's TTOO Position: Q4 2024 in Review

Armistice Capital sold out of T2 Biosystems, Inc (TTOO) in Q4 2024, closing a stake of 1,396,000 shares — an estimated $2.75M sold.

Armistice Capital first reported a position in TTOO in Q2 2024 and held it in 2 quarters. The position peaked at $8.85M in Q2 2024. 26 funds tracked by Wall St. Rank hold TTOO as of Q4 2024.

  • Armistice Capital reported no remaining T2 Biosystems, Inc position as of Q4 2024 after selling out during the quarter.
  • Armistice Capital sold 1,396,000 T2 Biosystems, Inc shares in Q4 2024, an estimated $2.75M.
  • Armistice Capital first reported a position in T2 Biosystems, Inc in Q2 2024 and held it in 2 quarters.
  • Armistice Capital's T2 Biosystems, Inc position peaked at $8.85M in Q2 2024.
  • 26 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2024.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.